These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11958428)

  • 1. Monteplase reduces infarct volume and hemorrhagic transformation in rat model of embolic stroke.
    Muramatsu H; Igarashi H; Okubo S; Katayama Y
    Neurol Res; 2002 Apr; 24(3):311-6. PubMed ID: 11958428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FK-506 extended the therapeutic time window for thrombolysis without increasing the risk of hemorrhagic transformation in an embolic rat stroke model.
    Okubo S; Igarashi H; Kanamatsu T; Hasegawa D; Orima H; Katayama Y
    Brain Res; 2007 Apr; 1143():221-7. PubMed ID: 17316578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early (1 h) administration of tissue plasminogen activator reduces infarct volume without increasing hemorrhagic transformation after focal cerebral embolization in rats.
    Zhang RL; Chopp M; Zhang ZG; Divine G
    J Neurol Sci; 1998 Sep; 160(1):1-8. PubMed ID: 9804110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model.
    Overgaard K; Sereghy T; Boysen G; Pedersen H; Diemer NH
    Scand J Clin Lab Invest; 1993 Jul; 53(4):383-93. PubMed ID: 8378742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke.
    Zhang L; Zhang ZG; Zhang RL; Lu M; Krams M; Chopp M
    Stroke; 2003 Jul; 34(7):1790-5. PubMed ID: 12805500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric ISODATA analysis of embolic stroke and rt-PA intervention in rat.
    Ding G; Jiang Q; Zhang L; Zhang Z; Knight RA; Soltanian-Zadeh H; Lu M; Ewing JR; Li Q; Whitton PA; Chopp M
    J Neurol Sci; 2004 Aug; 223(2):135-43. PubMed ID: 15337614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia.
    Zhang L; Zhang ZG; Zhang RL; Lu M; Adams J; Elliott PJ; Chopp M
    Stroke; 2001 Dec; 32(12):2926-31. PubMed ID: 11739997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed rt-PA treatment in a rat embolic stroke model: diagnosis and prognosis of ischemic injury and hemorrhagic transformation with magnetic resonance imaging.
    Dijkhuizen RM; Asahi M; Wu O; Rosen BR; Lo EH
    J Cereb Blood Flow Metab; 2001 Aug; 21(8):964-71. PubMed ID: 11487732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke.
    Lapchak PA; Araujo DM; Song D; Zivin JA
    Stroke; 2002 Jan; 33(1):147-52. PubMed ID: 11779904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
    Lu HT; Zhao JG; Li MH; Li YD
    Brain Res; 2012 Feb; 1438():75-84. PubMed ID: 22227456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant plasminogen activator timing on thrombolysis in a novel rat embolic stroke model.
    Ma Y; Li L; Niu Z; Song J; Lin Y; Zhang H; Du G
    Pharmacol Res; 2016 May; 107():291-299. PubMed ID: 27038532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
    Zhang L; Zhang ZG; Liu X; Hozeska A; Stagliano N; Riordan W; Lu M; Chopp M
    Thromb Haemost; 2006 Jan; 95(1):166-73. PubMed ID: 16543976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke.
    Zhang L; Zhang ZG; Zhang R; Morris D; Lu M; Coller BS; Chopp M
    Circulation; 2003 Jun; 107(22):2837-43. PubMed ID: 12756151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of infarction volume by bolus injection of pamiteplase, a modified tissue plasminogen activator with a longer half-life.
    Suzuki Y; Kano T; Katayama Y; Tejima E; Harada T
    Neurol Res; 2003 Jul; 25(5):477-80. PubMed ID: 12866195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke.
    Overgaard K; Sereghy T; Pedersen H; Boysen G
    Neurol Res; 1993 Oct; 15(5):344-9. PubMed ID: 7905610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postischemic intracarotid treatment with TNK-tPA reduces infarct volume and improves neurological deficits in embolic stroke in the unanesthetized rat.
    Zhang RL; Zhang L; Jiang Q; Zhang ZG; Goussev A; Chopp M
    Brain Res; 2000 Sep; 878(1-2):64-71. PubMed ID: 10996136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of pamiteplase, a modified t-PA, in a rat model of embolic stroke.
    Sumii T; Singhal AB; Asahi M; Shimizu-Sasamata M; Suzuki M; Miyata K; Lo EH
    Neuroreport; 2001 Mar; 12(3):615-8. PubMed ID: 11234775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis with rhPro-UK 3 to 6 hours after embolic stroke in rat.
    Hao CH; Ding WX; Sun Q; Li XX; Wang WT; Zhao ZY; Tang LD
    Neurol Res; 2019 Nov; 41(11):1034-1042. PubMed ID: 31584350
    [No Abstract]   [Full Text] [Related]  

  • 19. Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke.
    Morris DC; Zhang L; Zhang ZG; Lu M; Berens KL; Brown PM; Chopp M
    Stroke; 2001 Nov; 32(11):2635-40. PubMed ID: 11692028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of hemorrhagic transformation after thrombolytic therapy of clot embolism: an MRI investigation in rat brain.
    Neumann-Haefelin C; Brinker G; Uhlenküken U; Pillekamp F; Hossmann KA; Hoehn M
    Stroke; 2002 May; 33(5):1392-8. PubMed ID: 11988620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.